On 16 July, the European Commission published its proposal for the 2028–2034 Multiannual Financial Framework (MFF), outlining major structural changes to how the EU will
We are proud to announce that EUCAIM continues to grow! Following the successful launch of the 2024 Open Call, 19 new partners have officially joined
The European Commission’s Joint Research Centre (JRC) has published a new report on the future of AI in medical imaging, identifying current challenges and priority
EUCAIM is pleased to announce that Sweden has officially joined the list of countries that support a EUCAIM European Digital Infrastructure Consortium (EDIC) by submitting a
On 2 July 2025, the European Commission released its much-anticipated EU Life Sciences Strategy, setting a clear path toward global leadership in health and biomedical
The European Commission is establishing a Scientific Panel of Independent Experts to support the implementation and enforcement of the AI Act — a key framework
We’re inviting new partners to enhance our pan-European infrastructure for cancer images and artificial intelligence.
Whether you’re a data holder with valuable cancer images or an innovator developing AI tools for precision medicine, this is your chance to contribute to a groundbreaking project.
Apply by 10 June 2024!
We recently hosted a webinar with more details for prospective applicants to the open call. A recording is available.
EUCAIM is looking for your feedback! We have recently published a Stakeholder Survey in order to reach out to potential end-users and stakeholders. We believe that your insights could significantly contribute to understanding the expectations of potential users and identifying the essential aspects that stakeholders find crucial for future engagement and collaboration with the platform.
Therefore, we would like to invite you to participate in the Stakeholder Survey about the Cancer Image Europe platform.
Completing the survey will take approximately 10 minutes. Your participation is crucial to the success of this project, and we deeply appreciate your expertise in shaping the future of cancer imaging and treatment.